Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,202 | -160,995 | -119,686 | -75,878 | -34,452 |
| Depreciation Amortization | 2,505 | 431 | -1,369 | -1,986 | -255 |
| Accounts receivable | -587 | -320 | -19 | 219 | N/A |
| Accounts payable and accrued liabilities | 2,522 | -1,644 | 1,835 | 608 | 214 |
| Other Working Capital | -5,779 | 2,276 | 6,259 | 9,132 | 469 |
| Other Operating Activity | 4,598 | 27,906 | 16,850 | 10,669 | 4,747 |
| Operating Cash Flow | $-56,943 | $-132,346 | $-96,130 | $-57,236 | $-29,277 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -334,541 | -223,721 | -148,223 | -159,332 | -161,753 |
| PPE Investments | -304 | -134 | -127 | -30 | -16 |
| Net Acquisitions | N/A | -21,967 | -21,967 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -26,000 | -25,000 |
| Investing Cash Flow | $-334,845 | $-245,822 | $-170,317 | $-185,362 | $-186,769 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 393,219 | 153,906 | 54,801 | 701 | 682 |
| Other Financing Activity | -221 | -316 | -277 | -547 | -232 |
| Financing Cash Flow | $392,998 | $153,590 | $54,524 | $154 | $450 |
| Beginning Cash Position | 32,490 | 257,068 | 257,068 | 257,068 | 257,068 |
| End Cash Position | 33,700 | 32,490 | 45,145 | 14,624 | 41,472 |
| Net Cash Flow | $1,210 | $-224,578 | $-211,923 | $-242,444 | $-215,596 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,943 | -132,346 | -96,130 | -57,236 | -29,277 |
| Capital Expenditure | -304 | -134 | -127 | -30 | -16 |
| Free Cash Flow | -57,247 | -132,480 | -96,257 | -57,266 | -29,293 |